Atlas Trials

Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids

Clinical trial NCT01458912 · WITHDRAWN

Trial details

NCT number
NCT01458912
Sponsor
Boehringer Ingelheim
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2011-11-01
Primary completion
2013-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.